Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof
US-12030897-B2 · Jul 9, 2024 · US
Chen Xinde is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Chen Xinde |
| Total patents | 12 |
| First publication | Jan 11, 2018 |
| Latest publication | Jul 9, 2024 |
Publications ranked by popularity score, then publication date.
US-12030897-B2 · Jul 9, 2024 · US
US-2023212174-A1 · Jul 6, 2023 · US
US-11649239-B2 · May 16, 2023 · US
US-2023098398-A1 · Mar 30, 2023 · US
US-2021323979-A1 · Oct 21, 2021 · US
US-11117899-B2 · Sep 14, 2021 · US
US-2021094957-A1 · Apr 1, 2021 · US
US-10787422-B2 · Sep 29, 2020 · US
US-2020131184-A1 · Apr 30, 2020 · US
US-2019248751-A1 · Aug 15, 2019 · US
Latest publications not already listed above.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Medshine Discovery Inc | 6 |
| Shanghai Inst Materia Medica Cas | 4 |
| Tencent Tech Shenzhen Co Ltd | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 7 |
| A61P43/00 | 6 |
| C07D487/04 | 5 |
| A61P25/16 | 4 |
| C07D239/56 | 4 |